Actively Recruiting
Post-Market Follow-Up Study of the Solo Tympanostomy Tube Device for Ear Tube Insertion in Children and Adults
Led by AventaMed DAC · Updated on 2026-08-13
160
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect detailed information about the Solo Tympanostomy Tube Device Solo TTD, which is used to insert ear tubes for treating repeated or long-term middle ear infections and fluid buildup in the middle ear. The study includes both children and adults who have been treated, will be treated, or have had treatment attempts with this device. The Solo TTD is designed to place ear tubes using mainly topical anesthesia and does not require general anesthesia, unlike other similar devices. It is approved and in use in Europe. The study observes patients who have interacted with the Solo TTD device, gathering data from both those planned for the procedure prospective and those who already underwent it retrospective. The device is used to insert ear tubes across the eardrum to help ventilate the middle ear and drain fluid. The study collects information from doctor notes and patient or parentguardian feedback about their experiences with the procedure. Participants will have their medical records reviewed, and doctors notes will be collected regarding the use of the device and monitoring of the ear tubes after surgery. Patients and their parents or guardians will also provide views on the procedure. The study monitors procedure success, functioning of the tubes, and early adverse events over a 48-month period. The study runs from May 2026 to May 2030 and includes both adults and pediatric patients.
CONDITIONS
Brief Title
Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here